These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5929462)

  • 1. Purification and characterization of the vasodilator and antihypertensive lipid of rabbit renal medulla.
    Hickler RB; Birbari AE; Qureshi EU; Karnovsky ML
    Trans Assoc Am Physicians; 1966; 79():278-83. PubMed ID: 5929462
    [No Abstract]   [Full Text] [Related]  

  • 2. Derivation of antihypertensive neutral renomedullary lipid from renal venous effluent.
    Muirhead EE; Byers LW; Desiderio DM; Pitcock JA; Brooks B; Brown PS; Brosius WL
    J Lab Clin Med; 1982 Jan; 99(1):64-75. PubMed ID: 6798154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostaglandins].
    Yamamura Y; Kokubu T
    Naika; 1968 Oct; 22(4):891-9. PubMed ID: 5707877
    [No Abstract]   [Full Text] [Related]  

  • 4. The vasodepressor function of the kidney: prostaglandin E2 is not the principal vasodepressor lipid of the renal medulla.
    Glodny B; Pauli GF
    Acta Physiol (Oxf); 2006 Jul; 187(3):419-30. PubMed ID: 16776667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RENOMEDULLARY VASODEPRESSOR SUBSTANCE, MEDULLIN: ISOLATION, CHEMICAL CHARACTERIZATION AND PHYSIOLOGICAL PROPERTIES.
    LEE JB; COVINO BG; TAKMAN BH; SMITH ER
    Circ Res; 1965 Jul; 17():57-77. PubMed ID: 14302553
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension and human renal prostaglandins.
    Vance VK; Lee JB
    Med Ann Dist Columbia; 1973 Sep; 42(9):419-22. PubMed ID: 4590135
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of prostaglandin E2 as the principal vasodepressor lipid of rabbit renal medulla.
    Daniels EG; Hinman JW; Leach BE; Muirhead EE
    Nature; 1967 Sep; 215(5107):1298-9. PubMed ID: 4383206
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihypertensive renomedullary lipid in the hypertensive rabbit.
    Muirhead EE; Leach BE; Brooks B; Shaw PH; Brosius WL; Daniels EG; Hinman JW
    Rev Fr Etud Clin Biol; 1967 Nov; 12(9):893-8. PubMed ID: 5591338
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological mechanisms involved in the vasodilator effects of extracts from Echinodorus grandiflorus.
    TibiriƧƔ E; Almeida A; Caillleaux S; Pimenta D; Kaplan MA; Lessa MA; Figueiredo MR
    J Ethnopharmacol; 2007 Apr; 111(1):50-5. PubMed ID: 17150321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of antihypertensive drugs in kidney and liver diseases].
    Knauf H; Mutschler E
    MMW Munch Med Wochenschr; 1983 Nov; 125(45):1037-40. PubMed ID: 6139750
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive lipids from the kidney: alkyl ether analogs of phosphatidylcholine.
    Muirhead EE; Byers LW; Desiderio DM; Brooks B; Brosius WM
    Fed Proc; 1981 Jun; 40(8):2285-90. PubMed ID: 7016598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal vasodepressor lipid.
    Strong CG; Boucher R; Nowaczynski W; Genest J
    Mayo Clin Proc; 1966 Jul; 41(7):433-52. PubMed ID: 5937070
    [No Abstract]   [Full Text] [Related]  

  • 13. CHARACTERIZATION OF A VASODEPRESSOR LIPID OF THE RENAL MEDULLA.
    HICKLER RB; LAULER DP; SARAVIS CA; THORN GW
    Trans Assoc Am Physicians; 1964; 77():196-200. PubMed ID: 14275417
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasoactive substances in the lung.
    Said SI
    Aspen Emphysema Conf; 1967; 10():223-8. PubMed ID: 5610773
    [No Abstract]   [Full Text] [Related]  

  • 15. [Platelet-activating factor and antihypertensive polar renomedullary lipid: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine].
    Masugi F; Ogihara T; Kumahara Y
    Tanpakushitsu Kakusan Koso; 1982 Aug; 27(10):1342-7. PubMed ID: 6758041
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihypertensive activity of the kidney--the renomedullary prostaglandins.
    Lee JB
    N Engl J Med; 1967 Nov; 277(20):1073-9. PubMed ID: 4862525
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostacyclin and the vascular endothelium.
    Moncada S; Vane JR
    Bull Eur Physiopathol Respir; 1981; 17(4):687-701. PubMed ID: 7034824
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological studies on decanohydroxamic acid. 3. General pharmacological action. (2)].
    Kitagawa H; Yoshida S; Abe M; Ohno F
    Yakugaku Zasshi; 1965 Oct; 85(10):912-6. PubMed ID: 5893656
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal metabolism of sulindac, a novel nonsteroidal antiinflammatory agent.
    Miller MJ; Bednar MM; McGiff JC
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():487-91. PubMed ID: 6221568
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased renal prostaglandin E2 metabolism: a mechanism for the regulation of prostaglandin activity in acute renal failure.
    Chaudhari A; Kirschenbaum MA
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():543-6. PubMed ID: 6221577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.